KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Operating Leases (2019 - 2025)

Teladoc Health's Operating Leases history spans 7 years, with the latest figure at $34.2 million for Q4 2025.

  • For Q4 2025, Operating Leases rose 6.44% year-over-year to $34.2 million; the TTM value through Dec 2025 reached $34.2 million, up 6.44%, while the annual FY2025 figure was $34.2 million, 6.44% up from the prior year.
  • Operating Leases for Q4 2025 was $34.2 million at Teladoc Health, down from $48.0 million in the prior quarter.
  • Across five years, Operating Leases topped out at $48.4 million in Q2 2024 and bottomed at $32.1 million in Q4 2024.
  • The 5-year median for Operating Leases is $40.2 million (2021), against an average of $40.0 million.
  • The largest annual shift saw Operating Leases skyrocketed 40.9% in 2021 before it fell 24.98% in 2024.
  • A 5-year view of Operating Leases shows it stood at $41.8 million in 2021, then fell by 8.93% to $38.0 million in 2022, then grew by 12.6% to $42.8 million in 2023, then fell by 24.98% to $32.1 million in 2024, then increased by 6.44% to $34.2 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Operating Leases are $34.2 million (Q4 2025), $48.0 million (Q3 2025), and $41.9 million (Q2 2025).